Rosie was the first of three HNRNPH2 patients to receive treatment with an n-Lorem ASO, helping to pave the way for others. Her parents, Nicole and Bobby, share their daughter's journey and how they have adapted as a family to meet her unique needs. As a pediatrician, Nicole understands the complexities of medical care, yet she acknowledges that even she doesn’t always have the answers when it comes to raising a child with a nano-rare disease—a reality that resonates with many nano-rare families.
On this episode we discuss:
2:00 Bobby left his job to help care for Rosie full-time
7:36 Nicole is a pediatrician and it’s difficult for her to not regularly attend Rosie’s appointments
11:16 Rosie’s diagnosis of HNRNPH2
16:00 Even as a pediatrician, Nicole finds nano-rare diseases complex and difficult to navigate
19:29 What is HNRNPH2?
26:40 Coming to terms with the diagnosis
29:35 Weighing the potential risk/benefit and making the decision that Rosie will be the first HNRNPH2 patient treated with an experimental medicine
37:05 How Rosie is doing after three ASO treatment doses
40:35 Potential for a placebo effect and allowing multiple observers to notice changes
Podden och tillhörande omslagsbild på den här sidan tillhör
n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen). Innehållet i podden är skapat av n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen) och inte av,
eller tillsammans med, Poddtoppen.